FDA Modernization Act 2.0 has passed the US Senate

📢 As of Sept 29, the FDA Modernization Act 2.0 has passed the US Senate.   💡This bill marks a turning point in how animal testing is seen in drug development.  By stating that innovative technologies such as Organs-on-Chip and microphysiological systems can be used to evaluate drug safety and efficacy, the bill enables relevant validated human models to replace

More

Open letter for the FDA Modernization Act

🤔 Since 1938, the FDA has required that all drugs need to be tested in animal models prior to clinical trials. However, science and technology have advanced considerably in the past years. So, it is time to change!  💪 At AlveoliX we support the initiative of the FDA Modernization Act to recognize and implement legally the use of alternatives

More

AlveoliX is part of the 2022 Lush Prize shortlist

📢 Find out who is in the running for the 2022 Lush Prize! 🏅 We are very excited to have made it to the Shortlist among many great applicants with our project “A barrier-on-chip with integrated 3D stretching: an alternative predictive tool to support decision making”. 🤞 Let’s keep our fingers crossed! See you at the

More

AlveoliX winner of the Swiss Medtech Award 2022

🏆 We made it! We are the winner of the Swiss Medtech Award 2022 🙏 A big thank you to the AlveoliX team for their commitment and to all the people who support us.– ARTORG Center for Biomedical Engineering Research– Insel Gruppe– Innosuisse– Bern Economic Development Agency 👏🏼 Thank you to the jury for choosing AlveoliX and to the

More

Close collaboration with CSL and Insel Gruppe

🌐 CSL Behring, Insel Gruppe and AlveoliX have joined forces within sitem-insel AG’s hub to improve translation and find new treatments for lung diseases.  🔬 Discover how this close collaboration works for the benefit of patients. 📰  Learn more about this cooperation success story in this article by Jasmin Joller (available in EN, DE, FR). 

More

New partnership with InSCREENeX

🔥 We are very excited to announce our partnership with InSCREENeX GmbH. 🤝 By joining forces and combining InSCREENeX’ cutting-edge CI-SCREEN methodology with AlveoliX’ patented organ-on-chip technology, we co-developed a new immortalized alveolar cell line, specially tuned for on-chip applications. 🧫 AXiAECs derived from primary alveolar epithelial cells and grown on-chip feature key aspects of the distal

More

AlveoliX shortlisted for the Swiss Medtech Award 2022

🏅 AlveoliX has been shortlisted for the Swiss Medtech Award 2022!   🌟 We will be pitching our company to the Jury on April 6th. Looking forward to the hearing!  🙏🏻 Thank you Swiss Medtech for choosing AlveoliX as one of the 6 companies invited to participate in the vibrant Swiss Medtech Award 2022.  🔗 More info about the shortlisted

More

AlveoliX in the Top 5 Lab-on-a-Chip Solutions

🏆 AlveoliX is part of the Top 5 Startup out of 594 building Lab-on-a-Chip Solutions!  🔸 Interested in discovering other emerging technologies? Check out the article.  🙏🏼 Thank you StartUs Insights for featuring us. 

More

AlveoliX 3rd Anniversary

🎂 Happy Birthday to AlveoliX!🥂 We are thrilled and thankful to celebrate our 3rd anniversary.🤗 Thank you to all those who have trusted and supported us. We keep working to improve our range of applications and increase accessibility to our technology. Because we are stronger together.

More